Clovis Enters Bankruptcy With Deal to Sell Cancer-Drug Candidate to Novartis

Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with a proposed deal in hand to sell its rights to a cancer therapy under development...

Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More

Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...

SEC-targeted Chinese companies slump; Yum China warns of 2024 delisting risk

Shares of Chinese companies flagged for possible delisting in the U.S. slid in Hong Kong and Shanghai trading Friday, a move that analysts said highlighted geopolitical tensions but would have little ...

Alibaba and Other Chinese Stocks Got Crushed Thursday. Here’s Why.

Text size Chinese stocks including Alibaba fell on concerns they would eventually be delisted in the U.S. Qilai Shen/Bloomberg Alibaba (BABA), Yum China Holdings (YUMC), ACM Research (ACMR), Baidu (BI...